✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹93 Cr.
P/E
1.45
About
IND-SWIFT is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products. Ind-swift is a research driven forward … Read more
IND-SWIFT is Chandigarh based pharmaceutical company, established in 1986 with a mission of wi… Read more
Low
12
52W Range
High
35
  • Ind-Swift
  • Makers Laboratories
  • Biofil Chem & Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

10 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
80 %
(as of Mar 19)
Ind-Swift (Korea) - Market Share
50 %
(as of Mar 19)
Ivabradine Oxalate(Europe) - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Brand Wise Break-Up

Peer Comparison
FAQs on Ind-Swift Ltd. Business

IND-SWIFT, a Chandigarh-based pharmaceutical company established in 1986, focuses on innovative products. It specializes in finished goods dosage, active pharmaceutical ingredients (APIs), and herbal products, aiming to attract global customers.

Ind-Swift major competitors are Makers Laboratories, Biofil Chem & Pharma, Achyut Healthcare, Bharat Immunological, JFL Life Sciences, Dipna Pharma., Deccan Health Care.
Market Cap of Ind-Swift is ₹93 Crs.
While the median market cap of its peers are ₹82 Crs.

Ind-Swift seems to be less financially stable compared to its competitors.
Altman Z score of Ind-Swift is -0.84 and is ranked 8 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material